|
Mechanism5-HT receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date14 Aug 2002 |
100 Clinical Results associated with Yoshitomi Co., Ltd.
0 Patents (Medical) associated with Yoshitomi Co., Ltd.
100 Deals associated with Yoshitomi Co., Ltd.
100 Translational Medicine associated with Yoshitomi Co., Ltd.